OR WAIT null SECS
March 18, 2022
New report released by USP offers a look into API supply-chain vulnerabilities.
Sanofi is collaborating with Blackstone Life Sciences to accelerate the development of a treatment for multiple myeloma.
Emmes has acquired Casimir, marking its fourth major acquisition.
March 17, 2022
Viatris’ new drug-device is the first FDA-approved generic version of AstraZeneca’s Symbicort.
BioMed X and Merck KGaA, Darmstadt, Germany announced their collaboration on a research project to study T-cells and autoimmunity.
Envirotainer and Swiss WorldCargo have successfully completed the first commercial shipment using a new temperature-controlled air freight solution.
March 16, 2022
Novasep increases its production capacity for HPAPIs with an investment in its site in Le Mans, France.
EMA has recommended that possible side effects of Spikevax and Janssen COVID-19 vaccines be added to product information.
NIH has launched one of the first Phase 1 clinical trials to examine mRNA technology for HIV.
March 15, 2022
The US Congress approved a federal spending package that increases funding for a range of programs to advance health and medicine.